Literature DB >> 9806548

The Fanconi anaemia group G gene FANCG is identical with XRCC9.

J P de Winter1, Q Waisfisz, M A Rooimans, C G van Berkel, L Bosnoyan-Collins, N Alon, M Carreau, O Bender, I Demuth, D Schindler, J C Pronk, F Arwert, H Hoehn, M Digweed, M Buchwald, H Joenje.   

Abstract

Fanconi anemia (FA) is an autosomal recessive disease with diverse clinical symptoms including developmental anomalies, bone marrow failure and early occurrence of malignancies. In addition to spontaneous chromosome instability, FA cells exhibit cell cycle disturbances and hypersensitivity to cross-linking agents. Eight complementation groups (A-H) have been distinguished, each group possibly representing a distinct FA gene. The genes mutated in patients of complementation groups A (FANCA; refs 4,5) and C (FANCC; ref. 6) have been identified, and FANCD has been mapped to chromosome band 3p22-26 (ref. 7). An additional FA gene has recently been mapped to chromosome 9p (ref. 8). Here we report the identification of the gene mutated in group G, FANCG, on the basis of complementation of an FA-G cell line and the presence of pathogenic mutations in four FA-G patients. We identified the gene as human XRCC9, a gene which has been shown to complement the MMC-sensitive Chinese hamster mutant UV40, and is suspected to be involved in DNA post-replication repair or cell cycle checkpoint control. The gene is localized to chromosome band 9p13 (ref. 9), corresponding with a known localization of an FA gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806548     DOI: 10.1038/3093

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  63 in total

1.  Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines.

Authors:  S A Maxwell; G E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

2.  Several tetratricopeptide repeat (TPR) motifs of FANCG are required for assembly of the BRCA2/D1-D2-G-X3 complex, FANCD2 monoubiquitylation and phleomycin resistance.

Authors:  James B Wilson; Eric Blom; Ryan Cunningham; Yuxuan Xiao; Gary M Kupfer; Nigel J Jones
Journal:  Mutat Res       Date:  2010-05-05       Impact factor: 2.433

3.  Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A.

Authors:  H Joenje; M Levitus; Q Waisfisz; A D'Andrea; I Garcia-Higuera; T Pearson; C G van Berkel; M A Rooimans; N Morgan; C G Mathew; F Arwert
Journal:  Am J Hum Genet       Date:  2000-08-08       Impact factor: 11.025

Review 4.  Fanconi anaemia.

Authors:  M D Tischkowitz; S V Hodgson
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

Review 5.  Molecular pathogenesis of Fanconi anemia.

Authors:  Natalie Collins; Gary M Kupfer
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

6.  Evidence for subcomplexes in the Fanconi anemia pathway.

Authors:  Annette L Medhurst; El Houari Laghmani; Jurgen Steltenpool; Miriam Ferrer; Chantal Fontaine; Jan de Groot; Martin A Rooimans; Rik J Scheper; Amom Ruhikanta Meetei; Weidong Wang; Hans Joenje; Johan P de Winter
Journal:  Blood       Date:  2006-05-23       Impact factor: 22.113

7.  Differential p53 engagement in response to oxidative and oncogenic stresses in Fanconi anemia mice.

Authors:  Reena Rani; Jie Li; Qishen Pang
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

8.  Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice.

Authors:  Qing-Shuo Zhang; Weiliang Tang; Matthew Deater; Ngoc Phan; Andrea N Marcogliese; Hui Li; Muhsen Al-Dhalimy; Angela Major; Susan Olson; Raymond J Monnat; Markus Grompe
Journal:  Blood       Date:  2016-10-18       Impact factor: 22.113

9.  Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells.

Authors:  Kazuhiko Yamamoto; Masamichi Ishiai; Nobuko Matsushita; Hiroshi Arakawa; Jane E Lamerdin; Jean-Marie Buerstedde; Mitsune Tanimoto; Mine Harada; Larry H Thompson; Minoru Takata
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

Review 10.  PALB2: the hub of a network of tumor suppressors involved in DNA damage responses.

Authors:  Jung-Young Park; Fan Zhang; Paul R Andreassen
Journal:  Biochim Biophys Acta       Date:  2014-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.